Cutoff Values for Glycated Albumin, 1,5-Anhydroglucitol, and Fructosamine as Alternative Markers for Hyperglycemia

被引:0
|
作者
Yu, Hui-Jin [1 ]
Park, Chang-Hun [2 ]
Shin, Kangsu [3 ]
Woo, Hee-Yeon [3 ]
Park, Hyosoon [3 ]
Sung, Eunju [4 ]
Kwon, Min-Jung [3 ]
机构
[1] Seoul Med Ctr, Dept Lab Med, Seoul, South Korea
[2] Soonchunhyang Univ, Bucheon Hosp, Dept Lab Med & Genet, Coll Med, Bucheon, South Korea
[3] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea
关键词
1,5-anhydroglucitol; cutoff; diabetes; fructosamine; glycated albumin; hyperglycemia; GLYCEMIC CONTROL; SERUM 1,5-ANHYDROGLUCITOL; DIABETES-MELLITUS; CLINICAL MARKER; BLOOD-GLUCOSE; DISEASE; 1,5-ANHYDRO-D-GLUCITOL; ASSOCIATION; PREVALENCE; RISK;
D O I
10.1002/jcla.25097
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundGlycated albumin (GA), 1,5-anhydroglucitol (1,5-AG), and fructosamine have attracted considerable interest as markers of hyperglycemia. This study aimed to evaluate the optimal cutoff values for GA, 1,5-AG, and fructosamine and to determine their respective diagnostic efficacies in relation to hyperglycemia.MethodsWe enrolled 6012 individuals who had undergone fasting blood glucose (FBG) and Hemoglobin A1c (HbA1c) tests along with at least one alternative glycemic marker. Receiver operating characteristic (ROC) curves and the upper or lower limit of the reference range (97.5 or 2.5 percentiles) were used to ascertain the optimal cutoff values. Follow-up data from healthy individuals were used to identify patients who developed diabetes mellitus (DM).ResultsThe ROC cutoff values for GA, 1,5-AG, and fructosamine were 13.9%, 13.3 mu g/mL, and 278 mu mol/L, respectively, with corresponding area under the curve (AUC) values of 0.860, 0.879, and 0.834. The upper limits of the reference intervals for GA and fructosamine were 15.1% and 279 mu mol/L, respectively, and the lower limit for 1,5-AG was 5.3 mu g/mL. Among the GA cutoff values, the ROC cutoff had the highest sensitivity. Analyzing the follow-up data showed that lowering the GA cutoff from 16.0% to 13.9% identified an additional 40 people with DM progression.ConclusionsLowering the GA cutoff values significantly increased the sensitivity of DM diagnosis and enhanced its potential as a screening marker by identifying more individuals with diabetes progression. Conversely, modifications to the cutoff values for 1,5-AG and fructosamine did not confer any discernible diagnostic or predictive advantages. We assessed the optimal cut-off values for glycated albumin (GA), 1,5-anhydroglucitol (1,5-AG), and fructosamine using receiver operating characteristic (ROC) curve and the upper or lower limit of the reference range (97.5 or 2.5 percentiles). Lowering the GA cutoff values yielded a marked enhancement in sensitivity and detected more individuals with diabetes progression. In contrast, adjusting the cutoff values for 1,5-AG and fructosamine offered no noticeable diagnostic benefits.image
引用
收藏
页数:10
相关论文
共 50 条
  • [31] 1,5-anhydroglucitol promotes glycogenolysis in Escherichia coli
    Shiga, Y
    Kametani, S
    Kadokura, T
    Akanuma, H
    JOURNAL OF BIOCHEMISTRY, 1999, 125 (01): : 166 - 172
  • [32] Clinical usefulness of plasma 1,5-anhydroglucitol, fructosamine and blood HbAlc level in mice with abnormal glucose metabolism and in controls
    Tabata H.
    Kubo M.
    Suzuki H.
    Matsuzawa T.
    Kariya K.
    Comparative Haematology International, 1999, 9 (1): : 7 - 12
  • [33] Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test
    Su, Hang
    Wang, Yufei
    Ma, Xiaojing
    He, Xingxing
    Ying, Lingwen
    Tang, Junling
    Dong, Lu
    Bao, Yuqian
    Zhou, Jian
    Jia, Weiping
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [34] PLASMA 1,5-ANHYDROGLUCITOL IN EXPERIMENTAL GALACTOSEMIA IN THE RAT
    PITKANEN, E
    PITKANEN, OM
    EXPERIENTIA, 1990, 46 (01): : 85 - 87
  • [35] 1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES
    Wright, Lorena A.
    Hirsch, Irl B.
    Gooley, Ted A.
    Brown, Zane
    ENDOCRINE PRACTICE, 2015, 21 (07) : 725 - 733
  • [36] Production of 1,5-anhydroglucitol from 1,5-anhydrofructose in erythroleukemia cells
    Suzuki, M
    Kametani, S
    Uchida, K
    Akanuma, H
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (01): : 23 - 29
  • [37] 1,5-anhydroglucitol stimulates insulin secretion in insulinoma cells
    Inoue, Tae
    Ichiyanagi, Kaoru
    Yamanouchi, Toshikazu
    DIABETES, 2006, 55 : A590 - A590
  • [38] 1,5-Anhydroglucitol: A new diagnostic test for gestational diabetes?
    Harper, Lorie M.
    Jauk, Victoria C.
    Biggio, Joseph R.
    Topham-Corley, Glenda
    Szychowski, Jeff M.
    Casey, Brian M.
    Tita, Alan T.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S271 - S272
  • [39] The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus
    Xu, Haiying
    Chen, Renyin
    Hou, Xiaoli
    Li, Na
    Han, Yanwei
    Ji, Shaoping
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [40] 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes
    Dungan, Kathleen M.
    Buse, John B.
    Largay, Joseph
    Kelly, Mary M.
    Button, Eric A.
    Kato, Shuhei
    Wittlin, Steven
    DIABETES CARE, 2006, 29 (06) : 1214 - 1219